You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
As you would have been made aware from your physician, the Medtronic Valiant Navion™ Thoracic Stent Graft was recalled by Medtronic on February 17, 2021 with instructions to physicians to immediately cease use of the device in new patients. The recall is because Medtronic discovered that some patients with these devices developed a leak between the stent graft and the aorta. A “recall” means that the manufacturer has asked physicians to stop using the device with new patients; it does not mean that patients have been asked to have the device removed.
You were provided this communication because your physician’s information shows you have a Medtronic Valiant Navion™ Thoracic Stent Graft implanted to treat your condition. For patients who have the device, these leaks are generally treatable and can usually be detected with Computed Tomography (“CT”) imaging. The earlier a leak is detected, the sooner it may be treated. If left untreated, leaks can potentially lead to aneurysm rupture. For this reason, regular imaging is an important part of follow-up for all patients implanted with a Medtronic Valiant Navion™ Thoracic Stent Graft.
Since February, Medtronic has updated your physician to recommend more frequent imaging, considering conducting routine CT imaging with contrast of your stent every 6 months. Of course, your doctor may have individualized patient recommendations about whether or when you need imaging, or what type of imaging, and Medtronic defers to your doctor in those considerations.
We recognize this may be concerning to you. Please contact your doctor to speak about what this new recommendation may mean for you and your ongoing care.
Medtronic is committed to patient safety and will update physicians with any new recommendations or information related to your stent graft. We know that the greatest promise we make is to consistently produce safe medical technologies that alleviate pain, restore health and extend life for patients. We are committed keeping you informed, and continuously improving our products.
This stent graft (or stent as it’s commonly called) is a woven polyester tube (graft) supported by a strong but flexible metal frame (stent) and is used to support a weak spot in the aorta (the largest blood vessel in your chest).
Medtronic voluntarily initiated a recall of the Medtronic Valiant Navion™ Thoracic Stent Graft System and informed physicians to immediately cease use of the device in new patients as of February 2021. The recall was initiated because Medtronic, in consultation with external experts, discovered that some patients with these devices may develop a leak between the stent graft and the aorta. A “recall” does not mean that the manufacturer is asking that patients have the device removed.
For patients who already have this stent graft, such leaks are generally treatable and can usually be detected with Computed Tomography (“CT”) imaging. These leaks, if left untreated, can potentially lead to aneurysm rupture. Because of this, it is important that patients follow up regularly with their doctor to evaluate their health and the condition of their stent. Routine, ongoing surveillance has always been recommended for all patients who receive the Valiant Navion Thoracic Stent Graft System. The earlier a leak is detected, the sooner it can be evaluated for potential treatment. At this time, we are recommending patients seek routine CT imaging with contrast by your doctor every 6 months– unless your doctor decides this is not appropriate based on your individual medical situation.
Medtronic is working diligently to assess the causes of the issues observed with the Valiant Navion Thoracic Stent Graft System but has not yet determined the root cause of this issue. Preliminary analysis suggests the potential for a leak to develop between the stent graft and the aorta, which could lead to aneurysm rupture. Medtronic will make further updates as new information becomes available.
Medtronic is following up with physicians to recommend that they closely evaluate and monitor patients implanted with these stent grafts. Potential leaks are generally treatable and can usually be detected with Computed Tomography (“CT”) imaging. These leaks, if left untreated, can potentially lead to aneurysm rupture. It is important that you follow up regularly with your doctor to evaluate your health and to monitor your ongoing care. The earlier a leak is detected, the sooner it can be evaluated and potentially treated.
We recognize this may be concerning for you. Any leaks that may develop are generally treatable and can usually be detected with Computed Tomography (CT) imaging, but if left untreated, can potentially lead to aneurysm rupture. Please contact your doctor. It is important that you follow up with your doctor regularly to evaluate your health and monitor your stent graft and ongoing care.
Contact your doctor who is the best resource for you to ask about your Medtronic device and what it may mean to you and your and ongoing care and monitoring.
Based on the totality of the currently available data and in consultation with an Independent Physician Quality Panel (IPQP), Medtronic updated its recommendation that patients implanted with Valiant Navion Thoracic Stent Graft have computerized tomography (CT) imaging with contrast every six (6) months or as frequently as deemed appropriate in your physician’s medical judgment.
There are no specific symptoms associated with early stent issues, which is why we have updated existing imaging guidance recommending patients seek CT imaging with contrast by their doctor every six (6) months, or as frequently as deemed appropriate in the physician’s medical judgment. If you believe you may have experienced a complication with your stent, please contact your doctor immediately.
As part of our commitment to patient safety, Medtronic is developing a patient and physician support program and may provide financial assistance to physicians and their eligible patients to support the recommendation for more frequent follow-up imaging. To verify eligibility, and to improve its ongoing technical investigation and patient recommendations, Medtronic may request access to certain medical records, including imaging results.
Your doctor is the best resource for you to ask about your Medtronic device and what it may mean to you and your ongoing care.
A “recall” does not mean that the manufacturer is asking that patients have the device removed. With this recall, Medtronic informed physicians to immediately cease use of the device in new patients. For patients who already have the device, it is important that you and your doctor review your individual medical situation together and determine an appropriate plan for you and your treatment moving forward.